Labs / Assays & in vitro testing

Phenomic AI
Toronto, ON, Canada · phenomic.ai
Phenomic AI develops a machine-learning powered transcriptomics platform to identify drug targets and support discovery for solid tumors. It works on human cancer and normal tissue samples, as well as disease-relevant experimental systems such as human tumor explants and animal models. The company is focused on improving outcomes for hard-to-treat solid tumors.
They take quote requests by email.
What they offer
Target discovery for solid tumors
Uses single-cell RNA, imaging, and spatial transcriptomics data to identify novel, druggable targets in solid tumors.
Transcriptomics platform analysis
Applies machine learning to process RNA sequencing and spatial transcriptomics data at scale.
Single-cell target expression profiling
Profiles cell type and target expression in human cancer and normal tissue samples.
Human tumor explant testing
Uses human tumor explants to test drugs and generate translational insights during discovery.
Disease-relevant experimental system analysis
Explores biology in experimental systems including human tumor explants and animal models.
What they work on
- Modalities
- Antibody, Cell therapy, Gene editing
- Species and models
- human tissues, human cancer, normal tissue samples, human tumor explants, animal models
- Assays and studies
- single-cell RNA analysis, RNA sequencing, spatial transcriptomics, imaging analysis, translational testing, whole blood immune cell functional assays
- Scale and capacity
- single-cell data from human tissues at scale
- Therapeutic areas
- solid tumors, colorectal cancer, pancreatic cancer, breast cancer, immuno-oncology
- Address
- 180 John Street Phenomic AI
- Founded
- 2017
Similar labs. Altogen Labs, CDI Labs, Tetrad DISCOVERY, Virscio
Found in a contract services directory. Listing built from phenomic.ai. Work here? Claim this listing.